All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

econazole 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
systemic antifungal agents, miconazole derivatives	983	27220-47-9

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: econazole econazole nitrate ecostatin micofugal	An imidazole derivative that is commonly used as a topical antifungal agent. Molecular weight: 381.68 Formula: C18H15Cl3N2O CLOGP: 5.10 LIPINSKI: 1 HAC: 3 HDO: 0 TPSA: 27.05 ALOGS: -5.41 ROTB: 6 Status: OFP Legend: OFP - off patent OFM - off market ONP - on patent

Drug dosage:

Dose	Unit	Route
0.10	g	V

ADMET properties:

Property	Value	Reference
S (Water solubility)	0.00 mg/mL	Bocci G, Oprea TI, Benet LZ
BDDCS (Biopharmaceutical Drug Disposition Classification System)	2	Bocci G, Oprea TI, Benet LZ

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value	Unit	Confidence	Similarity
azlogd74	LogD at pH 7.4	4.869		High	1
caco2-efflux	Caco-2 efflux ratio (BA/AB)	1.799		High	1
caco2-intrinsic-papp	Caco-2 intrinsic apparent permeability	15.885	10^-6 cm/s	High	1
dh-clint	Dog hepatocyte intrinsic clearance	28.907	uL/min/10^6 cells	High	1
dppb	Dog plasma protein binding (% unbound)	0.190	%	High	1
fcs-ppb	Fetal calf serum protein binding (% unbound)	0.590	%	High	1
herg	hERG pIC50	5.777	pIC50	High	1
hh-clint	Human hepatocyte intrinsic clearance	14.757	uL/min/10^6 cells	High	1
hlm-clint	Human liver microsomal intrinsic clearance	46.026	uL/min/mg protein	High	1
hppb	Human plasma protein binding (% unbound)	0.380	%	High	1
kinase-safety-class	ACVR2A,ACVR2B,AKT2,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,GRK2,GSK3B,JAK2,MAP3K7,MAPK12,MAPK7,MAPK9,NTRK2,PDK2,PDK4,PDPK1,PIK3CB,PIK3CG,PIM2,PRKDC,SIK2,SIK3,STK33,TEK,TTK	35
kinase-selectivity-class	AKT2,AKT3,AXL,EIF2AK3,GRK2,PDK4	6
mdck-mdr1-efflux	MDCK-MDR1 efflux ratio	0.392		High	1
mh-clint	Mouse hepatocyte intrinsic clearance	40.551		High	1
mppb	Mouse plasma protein binding (% unbound)	0.280		High	1
nih-mdck-mdr1-efflux	NIH MDCK-MDR1 efflux ratio	1.164		High	1
pfas-class	PFAS structural alert (1 = True, 0 = False)	0
pppb	Pig plasma protein binding (% unbound)	0.690	%	High	1
rh-clint	Rat hepatocyte intrinsic clearance	53.211	uL/min/10^6 cells	High	1
rh-fuinc	Rat hepatocyte fraction unbound in incubation	3.020	%	High	1
rppb	Rat plasma protein binding (% unbound)	0.240	%	High	1
solubility-dd	Solubility at pH 7.4 in DMSO	30.620	uM	High	1

Approvals:

Date	Agency	Company	Orphan
Dec. 23, 1982	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Acute generalised exanthematous pustulosis	136.04	27.28	39	2913	13664	90611831
Acute motor-sensory axonal neuropathy	98.90	27.28	16	2936	359	90625136
Rash maculo-papular	94.24	27.28	39	2913	40894	90584601
Angiodermatitis	86.15	27.28	13	2939	182	90625313
International normalised ratio increased	66.76	27.28	32	2920	47284	90578211
Eosinophilia	61.65	27.28	26	2926	28507	90596988
Dermatitis exfoliative generalised	51.38	27.28	15	2937	5578	90619917
Drug reaction with eosinophilia and systemic symptoms	48.68	27.28	25	2927	42733	90582762
Purpura	47.72	27.28	18	2934	14760	90610735
Tarsal tunnel syndrome	46.58	27.28	9	2943	568	90624927
Purpura senile	46.00	27.28	9	2943	606	90624889
Lip oedema	45.09	27.28	13	2939	4626	90620869
Hypothalamic pituitary adrenal axis suppression	44.73	27.28	8	2944	330	90625165
Oedema mouth	43.58	27.28	11	2941	2375	90623120
Drug interaction	43.29	27.28	49	2903	276404	90349091
Gastrointestinal ulcer haemorrhage	42.21	27.28	9	2943	929	90624566
Granulomatous liver disease	42.11	27.28	9	2943	940	90624555
Resorption bone increased	39.87	27.28	9	2943	1210	90624285
Vestibular disorder	37.72	27.28	9	2943	1540	90623955
Pyelonephritis	31.82	27.28	15	2937	21301	90604194
Folate deficiency	31.34	27.28	9	2943	3156	90622339
Renal failure	30.95	27.28	29	2923	130978	90494517
Rash pustular	30.39	27.28	11	2941	8038	90617457
Hepatitis cholestatic	29.72	27.28	11	2941	8550	90616945
Rash scarlatiniform	27.89	27.28	5	2947	209	90625286

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Procedural haemorrhage	43.35	24.92	11	1183	2830	42617311
Pulmonary haemorrhage	28.30	24.92	11	1183	11386	42608755
Essential tremor	26.85	24.92	6	1188	897	42619244
Toxic skin eruption	26.32	24.92	11	1183	13719	42606422
Rash maculo-papular	26.01	24.92	15	1179	37488	42582653

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Acute generalised exanthematous pustulosis	145.84	22.87	46	3661	21618	110563974
Rash maculo-papular	115.03	22.87	54	3653	74168	110511424
Acute motor-sensory axonal neuropathy	92.66	22.87	16	3691	522	110585070
Angiodermatitis	85.38	22.87	13	3694	188	110585404
International normalised ratio increased	70.59	22.87	41	3666	86731	110498861
Eosinophilia	62.55	22.87	33	3674	57903	110527689
Drug reaction with eosinophilia and systemic symptoms	62.06	22.87	37	3670	82058	110503534
Purpura	51.31	22.87	22	3685	24366	110561226
Tarsal tunnel syndrome	46.76	22.87	9	3698	540	110585052
Purpura senile	45.74	22.87	9	3698	606	110584986
Dermatitis exfoliative generalised	41.02	22.87	15	3692	10957	110574635
Toxic skin eruption	39.45	22.87	19	3688	27496	110558096
Hypothalamic pituitary adrenal axis suppression	38.89	22.87	8	3699	674	110584918
Resorption bone increased	37.55	22.87	9	3698	1525	110584067
Gastrointestinal ulcer haemorrhage	36.90	22.87	9	3698	1641	110583951
Oedema mouth	35.69	22.87	10	3697	3120	110582472
Lip oedema	34.50	22.87	12	3695	7588	110578004
Procedural haemorrhage	34.32	22.87	11	3696	5416	110580176
Drug interaction	33.52	22.87	60	3647	500123	110085469
Rash papular	33.42	22.87	17	3690	27622	110557970
Vestibular disorder	32.73	22.87	9	3698	2623	110582969
Granulomatous liver disease	32.18	22.87	8	3699	1576	110584016
Pyelonephritis	31.91	22.87	16	3691	25234	110560358
Rash pustular	28.39	22.87	12	3695	12817	110572775
Folate deficiency	28.08	22.87	9	3698	4429	110581163
Renal failure	26.17	22.87	35	3672	226539	110359053
Status epilepticus	25.86	22.87	15	3692	31556	110554036
Rash scarlatiniform	25.04	22.87	5	3702	363	110585229
Vertigo positional	24.96	22.87	8	3699	3940	110581652
Skin ulcer	24.72	22.87	19	3688	63626	110521966
Cholestasis	24.49	22.87	19	3688	64499	110521093

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	D01AC03	DERMATOLOGICALS ANTIFUNGALS FOR DERMATOLOGICAL USE ANTIFUNGALS FOR TOPICAL USE Imidazole and triazole derivatives
ATC	G01AF05	GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Imidazole derivatives
ATC	G01AF55	GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Imidazole derivatives
FDA CS	M0002083	Azoles
FDA EPC	N0000175487	Azole Antifungal
MeSH PA	D000890	Anti-Infective Agents
MeSH PA	D000935	Antifungal Agents
MeSH PA	D004791	Enzyme Inhibitors
MeSH PA	D006727	Hormone Antagonists
MeSH PA	D058888	14-alpha Demethylase Inhibitors
MeSH PA	D065088	Steroid Synthesis Inhibitors
MeSH PA	D065607	Cytochrome P-450 Enzyme Inhibitors

Related Drugs by ATC class:

D01AC Imidazole and triazole derivatives 20 drugs

bifonazolechlormidazoleclotrimazoleeberconazoleefinaconazolefenticonazolefluconazoleflutrimazoleisoconazoleketoconazolelanoconazoleluliconazole show all 20 →

G01AF Imidazole derivatives 16 drugs

azanidazolebutoconazoleclotrimazolefenticonazoleflutrimazoleisoconazoleketoconazolemetronidazolemiconazoleomoconazoleornidazoleoxiconazole show all 16 →

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Tinea pedis	indication	6020002	DOID:12403
Candidiasis of skin	indication	49883006
Pityriasis versicolor	indication	56454009	DOID:9060
Tinea corporis	indication	84849002
Tinea cruris	indication	399029005
Paronychia	off-label use	71906005	DOID:13117

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	6.49	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Cannabinoid receptor 1	GPCR	P21554	CNR1_HUMAN		Ki	4.54		DRUG MATRIX
Mu-type opioid receptor	GPCR	P35372	OPRM_HUMAN		Ki	5.64		DRUG MATRIX
D(1A) dopamine receptor	GPCR	P21728	DRD1_HUMAN		Ki	5.34		DRUG MATRIX
D(2) dopamine receptor	GPCR	P14416	DRD2_HUMAN		Ki	5.37		DRUG MATRIX
Adenosine receptor A2a	GPCR	P29274	AA2AR_HUMAN		Ki	5.09		DRUG MATRIX
Alpha-2A adrenergic receptor	GPCR	P08913	ADA2A_HUMAN		Ki	5.79		DRUG MATRIX
Sigma non-opioid intracellular receptor 1	Membrane receptor	Q99720	SGMR1_HUMAN		Ki	5.05		DRUG MATRIX
Cytochrome P450 3A4	Enzyme	P08684	CP3A4_HUMAN		IC50	7.30		DRUG MATRIX
Sodium-dependent serotonin transporter	Transporter	P31645	SC6A4_HUMAN		Ki	6.65		DRUG MATRIX
Sodium-dependent noradrenaline transporter	Transporter	P23975	SC6A2_HUMAN		Ki	5.62		DRUG MATRIX
5-hydroxytryptamine receptor 1A	GPCR	P08908	5HT1A_HUMAN		Ki	5.03		DRUG MATRIX
5-hydroxytryptamine receptor 2A	GPCR	P28223	5HT2A_HUMAN		Ki	5.94		DRUG MATRIX
5-hydroxytryptamine receptor 2B	GPCR	P41595	5HT2B_HUMAN		Ki	5.36		DRUG MATRIX
5-hydroxytryptamine receptor 2C	GPCR	P28335	5HT2C_HUMAN		Ki	5.20		DRUG MATRIX
5-hydroxytryptamine receptor 6	GPCR	P50406	5HT6R_HUMAN		Ki	5.30		DRUG MATRIX
Alpha-2B adrenergic receptor	GPCR	P18089	ADA2B_HUMAN		Ki	5.57		DRUG MATRIX
D(3) dopamine receptor	GPCR	P35462	DRD3_HUMAN		Ki	5.79		DRUG MATRIX
Histamine H2 receptor	GPCR	P25021	HRH2_HUMAN		Ki	5.81		DRUG MATRIX
Muscarinic acetylcholine receptor M1	GPCR	P11229	ACM1_HUMAN		Ki	6.20		DRUG MATRIX
Muscarinic acetylcholine receptor M2	GPCR	P08172	ACM2_HUMAN		Ki	5.94		DRUG MATRIX
Muscarinic acetylcholine receptor M3	GPCR	P20309	ACM3_HUMAN		Ki	6.42		DRUG MATRIX
Muscarinic acetylcholine receptor M4	GPCR	P08173	ACM4_HUMAN		Ki	6.53		DRUG MATRIX
Beta-3 adrenergic receptor	GPCR	P13945	ADRB3_HUMAN		Ki	5.34		DRUG MATRIX
Sodium-dependent dopamine transporter	Transporter	Q01959	SC6A3_HUMAN		Ki	6.18		DRUG MATRIX
Cytochrome P450 2D6	Enzyme	P10635	CP2D6_HUMAN		IC50	6.40		DRUG MATRIX
Adenosine receptor A1	GPCR	P30542	AA1R_HUMAN		Ki	5.01		DRUG MATRIX
Adenosine receptor A3	GPCR	P0DMS8	AA3R_HUMAN		Ki	5.74		DRUG MATRIX
D(4) dopamine receptor	GPCR	P21917	DRD4_HUMAN		Ki	5.49		DRUG MATRIX
Alpha-1D adrenergic receptor	GPCR	P25100	ADA1D_HUMAN		Ki	5.36		DRUG MATRIX
Kappa-type opioid receptor	GPCR	P41145	OPRK_HUMAN		Ki	5.46		DRUG MATRIX
Delta-type opioid receptor	GPCR	P41143	OPRD_HUMAN		Ki	6.29		DRUG MATRIX
Acetylcholinesterase	Enzyme	P22303	ACES_HUMAN		IC50	4.86		DRUG MATRIX
Cytochrome P450 2C9	Enzyme	P11712	CP2C9_HUMAN		IC50	6.70		DRUG MATRIX
Cytochrome P450 1A2	Enzyme	P05177	CP1A2_HUMAN		IC50	6.52		DRUG MATRIX
Epidermal growth factor receptor	Kinase	P00533	EGFR_HUMAN		IC50	4.49		DRUG MATRIX
Substance-P receptor	GPCR	P25103	NK1R_HUMAN		Ki	5.19		DRUG MATRIX
Steroid 17-alpha-hydroxylase/17,20 lyase	Enzyme	P05093	CP17A_HUMAN		Ki	6.49		CHEMBL
Cytochrome P450 2C19	Enzyme	P33261	CP2CJ_HUMAN		IC50	7.40		DRUG MATRIX
Tyrosine-protein kinase Fyn	Kinase	P06241	FYN_HUMAN		IC50	4.92		DRUG MATRIX
Receptor tyrosine-protein kinase erbB-2	Kinase	P04626	ERBB2_HUMAN		IC50	4.86		DRUG MATRIX
Thromboxane-A synthase	Enzyme	P24557	THAS_HUMAN		IC50	7.54		DRUG MATRIX
Lanosterol 14-alpha demethylase	Enzyme	Q16850	CP51A_HUMAN		IC50	7.30		CHEMBL
Matrix metalloproteinase-9	Enzyme	P14780	MMP9_HUMAN		IC50	5.16		DRUG MATRIX
Indoleamine 2,3-dioxygenase 1	Enzyme	P14902	I23O1_HUMAN		IC50	5.09		CHEMBL
Substance-K receptor	GPCR	P21452	NK2R_HUMAN		Ki	5.70		DRUG MATRIX
Transient receptor potential cation channel subfamily M member 2	Ion channel	O94759	TRPM2_HUMAN		IC50	5.52		CHEMBL
Melanocortin receptor 5	GPCR	P33032	MC5R_HUMAN		Ki	4.43		DRUG MATRIX
Melanocortin receptor 3	GPCR	P41968	MC3R_HUMAN		Ki	4.50		DRUG MATRIX
Neuropeptide Y receptor type 2	GPCR	P49146	NPY2R_HUMAN		Ki	4.96		DRUG MATRIX
Transient receptor potential cation channel subfamily M member 8	Ion channel	Q7Z2W7	TRPM8_HUMAN		IC50	6.38		CHEMBL
Malate dehydrogenase cytoplasmic	Enzyme	P40925	MDHC_HUMAN		IC50	4.60		CHEMBL
Calcium release-activated calcium channel protein 1	Ion channel	Q96D31	CRCM1_HUMAN		IC50	4.77		CHEMBL
Beta-1 adrenergic receptor	GPCR	P08588	ADRB1_HUMAN		Ki	5.13		DRUG MATRIX
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	Enzyme	Q9UNU6	CP8B1_HUMAN		IC50	6.51		CHEMBL
Lanosterol 14-alpha demethylase	Enzyme		CP51_CANAL	INHIBITOR				CHEMBL	CHEMBL
Beta-lactamase	Enzyme		AMPC_ECOLI		IC50	4.60		CHEMBL
Androgen receptor	Transcription factor		ANDR_RAT		Ki	5.17		DRUG MATRIX
5-hydroxytryptamine receptor 1B	GPCR		5HT1B_RAT		Ki	5.00		DRUG MATRIX
Membrane-associated progesterone receptor component 1	Membrane receptor		PGRC1_RAT		Ki	5.50		DRUG MATRIX
Progesterone receptor	Transcription factor		Q690N0_BOVIN		Ki	5.88		DRUG MATRIX
Alpha-1A adrenergic receptor	GPCR		ADA1A_RAT		IC50	4.67		CHEMBL
5-hydroxytryptamine receptor 1A	GPCR		5HT1A_RAT		IC50	4.79		CHEMBL
Acetylcholinesterase	Enzyme		ACES_ELEEL		IC50	4.65		CHEMBL
Cholinesterase	Enzyme		CHLE_HORSE		IC50	4.76		CHEMBL
Lanosterol 14-alpha demethylase	Enzyme		CP51_MYCTU		Kd	6.70		CHEMBL
Indoleamine 2,3-dioxygenase 2	Enzyme		I23O2_MOUSE		IC50	5.12		CHEMBL
Mycocyclosin synthase	Enzyme		CP121_MYCTU		Kd	7.14		CHEMBL
Indoleamine 2,3-dioxygenase 1	Enzyme		I23O1_MOUSE		IC50	4.95		CHEMBL

External reference:

ID	Source
4019740	VUID
N0000147832	NUI
D00881	KEGG_DRUG
24169-02-6	SECONDARY_CAS_RN
4018560	VANDF
4019740	VANDF
C0013547	UMLSCUI
CHEBI:4754	CHEBI
CHEMBL808	ChEMBL_ID
CHEMBL1201049	ChEMBL_ID
DB01127	DRUGBANK_ID
D004464	MESH_DESCRIPTOR_UI
3198	PUBCHEM_CID
2446	IUPHAR_LIGAND_ID
3189	INN_ID
6Z1Y2V4A7M	UNII
142434	RXNORM
400323	MMSL
45569	MMSL
4650	MMSL
002923	NDDF
002924	NDDF
18952006	SNOMEDCT_US
373471002	SNOMEDCT_US
73827006	SNOMEDCT_US
ECN	PDB_CHEM_ID

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	21695-892	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	21922-111	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	33261-956	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	45802-466	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	51672-1303	CREAM	10 mg	TOPICAL	ANDA	20 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	52565-022	CREAM	10 mg	TOPICAL	ANDA	18 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	54868-5042	CREAM	10 mg	TOPICAL	ANDA	17 sections
ECONAZOLE NITRATE	Human Prescription Drug Label	1	59651-945	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	63629-8645	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	63629-8646	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	63629-8647	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	67296-0479	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	67296-1239	CREAM	10 mg	TOPICAL	ANDA	20 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	68788-8170	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	68788-8174	CREAM	10 mg	TOPICAL	ANDA	20 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	68788-8884	CREAM	10 mg	TOPICAL	ANDA	17 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	72162-1410	CREAM	10 mg	TOPICAL	ANDA	17 sections
PM EXTERNAL	HUMAN OTC DRUG LABEL	4	72689-0038	SOLUTION	10 mg	TOPICAL	unapproved drug other	7 sections
ECONAZOLE NITRATE 1% / NIACINAMIDE 4%	HUMAN PRESCRIPTION DRUG LABEL	2	72934-2073	CREAM	1 g	TOPICAL	unapproved drug other	4 sections
071023 ECONAZOLE NITRATE 1% / NIACINAMIDE 4%	HUMAN PRESCRIPTION DRUG LABEL	2	72934-2218	CREAM	1 g	TOPICAL	unapproved drug other	4 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	73352-100	AEROSOL, FOAM	10 mg	TOPICAL	NDA	30 sections
Econazole Nitrate	HUMAN PRESCRIPTION DRUG LABEL	1	73352-100	AEROSOL, FOAM	10 mg	TOPICAL	NDA	30 sections
Ecoza	HUMAN PRESCRIPTION DRUG LABEL	1	81811-100	AEROSOL, FOAM	10 mg	TOPICAL	NDA	30 sections